- Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
-
Ahn YJ, Hwang HB, Chung SK
- KMID: 1792113
- Korean J Ophthalmol.
- 2014 Apr;28(2):177-180.
- doi: 10.3341/kjo.2014.28.2.177
Vascular endothelial growth factor inhibitor is an emerging therapeutic modality for various ocular diseases with neovascularization (NV). However, for corneal NV, controversy remains regarding whether bevacizumab or ranibizumab is superior.... -
- CITED
-
- Close
- SHARE
-
- Close
- Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma
-
Jang JH, Kim KH, Lee SJ, Park JM
- KMID: 1499690
- Korean J Ophthalmol.
- 2012 Dec;26(6):478-480.
- doi: 10.3341/kjo.2012.26.6.478
Choroidal osteoma is a benign ossified tumor that is found predominantly in healthy young women during their second and third decades of life. The lesions are white-to-cream or orange in... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
-
Ryoo NK, Lee EJ, Kim TW
- KMID: 1705429
- Korean J Ophthalmol.
- 2013 Aug;27(4):299-303.
- doi: 10.3341/kjo.2013.27.4.299
To describe three cases of neovascular glaucoma (NVG) where iris or angle neovascularization regressed remarkably after subconjunctival bevacizumab injections used as the initial treatment before pan retinal photocoagulation (PRP) and/or... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Injection of Intravitreal Drugs with Standard Care in Macular Edema Secondary to Branch Retinal Vein Occlusion
-
Lee K, Jung H, Sohn J
- KMID: 1792090
- Korean J Ophthalmol.
- 2014 Feb;28(1):19-25.
- doi: 10.3341/kjo.2014.28.1.19
PURPOSE: To compare the long-term efficacy and safety of intravitreal triamcinolon with or without rescue laser therapy (intravitreal triamcinolone injection [IVTA] group), bevacizumab with or without rescue laser treatment (intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Patient Pain Experience during Intravitreal 27-Gauge Bevacizumab and 30-Gauge Ranibizumab Injection
-
Guler M, Bilgin B, Capkin M, Simsek A, Bilak S
- KMID: 2363758
- Korean J Ophthalmol.
- 2015 Jun;29(3):190-194.
- doi: 10.3341/kjo.2015.29.3.190
PURPOSE: To compare pain scores of patients during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection procedures. METHODS: Seventy eyes of 70 patients who had not previously undergone intravitreal anti-vascular endothelial growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
-
Wang D, Choi KS, Lee SJ
- KMID: 1792092
- Korean J Ophthalmol.
- 2014 Feb;28(1):32-38.
- doi: 10.3341/kjo.2014.28.1.32
PURPOSE: This study compared serum vascular endothelial growth factor (VEGF) concentration between patients given the bilateral and unilateral intravitreal injections of bevacizumab. METHODS: In a prospective manner, serum VEGF levels in... -
- CITED
-
- Close
- SHARE
-
- Close
- Trastuzumab-Conjugated Liposome-Coated Fluorescent Magnetic Nanoparticles to Target Breast Cancer
-
Jang M, Yoon YI, Kwon YS, Yoon TJ, Lee HJ, Hwang SI, Yun BL, Kim SM
- KMID: 1731043
- Korean J Radiol.
- 2014 Aug;15(4):411-422.
- doi: 10.3348/kjr.2014.15.4.411
OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
-
Shin JY, Woo SJ, Ahn J, Park KH
- KMID: 1792078
- Korean J Ophthalmol.
- 2013 Dec;27(6):425-432.
- doi: 10.3341/kjo.2013.27.6.425
PURPOSE: To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections (ranibizumab, bevacizumab) and their responses to... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
-
Lim JW, Park JH
- KMID: 1018419
- Korean J Ophthalmol.
- 2011 Aug;25(4):282-284.
- doi: 10.3341/kjo.2011.25.4.282
We report a case of posterior scleritis effectively managed with intravitreal bevacizumab. A 71-year-old woman was diagnosed with posterior scleritis. Although she was initially treated with systemic steroids, her clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
-
Entezari M, Ramezani A, Yaseri M
- KMID: 1364869
- Korean J Ophthalmol.
- 2012 Apr;26(2):139-142.
- doi: 10.3341/kjo.2012.26.2.139
In a clinical case series, 5 patients with not-resolved central serous choroidoretinopathy (CSC) lasting more than 1 year received one intravitreal bevacizumab injection (IVB, 1.25 mg) injection. All patients underwent... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacogenetic Influence of LOC387715/HTRA1 on the Efficacy of Bevacizumab Treatment for Age-Related Macular Degeneration in a Korean Population
-
Kang HK, Yoon MH, Lee DH, Chin HS
- KMID: 1499678
- Korean J Ophthalmol.
- 2012 Dec;26(6):414-422.
- doi: 10.3341/kjo.2012.26.6.414
PURPOSE: The purpose of this study was to determine the pharmacogenetic effects of complement factor H (CFH) Y402H, LOC387715 and high-temperature requirement factor A1 (HTRA1) genotypes on the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
-
Kim HW, Kim JL, Lee MH, Yoo HG, Chung IY, Lee JE
- KMID: 1018409
- Korean J Ophthalmol.
- 2011 Aug;25(4):231-237.
- doi: 10.3341/kjo.2011.25.4.231
PURPOSE: To evaluate the outcome of a combined photodynamic therapy and intravitreal injection of bevacizumab in choroidal neovascularization secondary to age-related macular degeneration. METHODS: Photodynamic therapy (PDT) was administered to 28... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema
-
Lee SJ, Kim ET, Moon YS
- KMID: 1098630
- Korean J Ophthalmol.
- 2011 Oct;25(5):299-304.
- doi: 10.3341/kjo.2011.25.5.299
PURPOSE: To compare the efficacy between intravitreal bevacizumab and combination treatment (bevacizumab and macular photocoagulation) for the treatment of diabetic macular edema (DME). In addtion, changes of DME type were... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Bevacizumab on Extraocular Muscle in a Rabbit Model
-
Jung JH, Lee JH, Lee JE, Choi HY
- KMID: 1387397
- Korean J Ophthalmol.
- 2012 Aug;26(4):290-296.
- doi: 10.3341/kjo.2012.26.4.290
PURPOSE: The purpose of this study was to investigate the myotoxicity of bevacizumab on extraocular muscles in a rabbit model. METHODS: Thirty New Zealand white rabbits were used for this study.... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
-
Cho HJ, Baek JS, Lee DW, Kim CG, Kim JW
- KMID: 1376119
- Korean J Ophthalmol.
- 2012 Jun;26(3):157-162.
- doi: 10.3341/kjo.2012.26.3.157
PURPOSE: To compare the effectiveness of intravitreal injections of bevacizumab and ranibizumab in patients with treatment-naive polypoidal choroidal vasculopathy (PCV). METHODS: Records from 106 consecutive patients who received intraviteral bevacizumab (n... -
- CITED
-
- Close
- SHARE
-
- Close
